HomeInsightsStock Comparison

Lupin Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Lupin Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Lupin Ltd is ₹ 1865 as of 01 Aug 15:30.
  • The P/E Ratio of Lupin Ltd changed from 38.1 on March 2021 to 28.2 on March 2025 . This represents a CAGR of -5.84% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 38.1 on March 2025 . This represents a CAGR of 9.18% over 6 years.
  • The Market Cap of Lupin Ltd changed from ₹ 26713 crore on March 2020 to ₹ 92522 crore on March 2025 . This represents a CAGR of 23.00% over 6 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 416392 crore on March 2025 . This represents a CAGR of 30.45% over 6 years.
  • The revenue of Lupin Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 5724 crore. This represent the decline of -100% The revenue of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 14315 crore as compare to the Mar '25 revenue of ₹ 13571 crore. This represent the growth of 5.48%.
  • The ebitda of Lupin Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 1378 crore. This represent the decline of -100% The ebitda of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 3948 crore as compare to the Mar '25 ebitda of ₹ 3967 crore. This represent the decline of -0.48%.
  • The net profit of Lupin Ltd changed from ₹ 453.33 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2302 crore over 9 quarters. This represents a CAGR of 6.16% .
  • The Dividend Payout of Lupin Ltd changed from 37.36 % on March 2020 to 13.79 % on March 2025 . This represents a CAGR of -15.30% over 6 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 89.64 % on March 2025 . This represents a CAGR of 20.09% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited.
  • In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited.
  • In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Lupin Ltd News Hub

News

Lupin Ltd gains for fifth session

Lupin Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1975.9, ...

Read more

29 Jul 2025 13:00

News

Lupin announces board meeting date

Lupin will hold a meeting of the Board of Directors of the Company on 5 August 2025. Power...

Read more

22 Jul 2025 10:47

News

Lupin's arm receives GMP certification from Australia's TGA

The certification applies to LMS's active pharmaceutical ingredient (API) manufacturing fa...

Read more

18 Jul 2025 10:41

News

Lupin launches Loteprednol Etabonate Ophthalmic Suspension in the United States

Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax' Ophthalmic ...

Read more

16 Jul 2025 15:45

News

Lupin launches Loteprednol Etabonate Ophthalmic Suspension in US

Lupin today announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in ...

Read more

16 Jul 2025 18:04

News

Lupin to hold AGM

Lupin announced that the 43th Annual General Meeting(AGM) of the company will be held on 1...

Read more

15 Jul 2025 17:38

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma drops after Q1 PAT slips 20% YoY to Rs 2,279 cr

The drop in profit was primarily due to a one-time exceptional charge of Rs 818 crore duri...

Read more

31 Jul 2025 15:46

News

Sun Pharmaceutical Industries Ltd spurts 0.66%, up for five straight sessions

Sun Pharmaceutical Industries Ltd rose for a fifth straight session today. The stock is qu...

Read more

29 Jul 2025 13:00

News

Sun Pharma announces top-line results of tildrakizumab 100 mg Phase 3 studies

Sun Pharmaceutical Industries announced top-line results from two Phase 3 clinical studies...

Read more

21 Jul 2025 09:05

News

Sun Pharmaceutical Industries Ltd spurts 2.56%, rises for third straight session

Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is qu...

Read more

15 Jul 2025 13:05

News

Sun Pharma launches Leqselvi in US; settles litigation with Incyte Corp

The drug is indicated for the treatment of alopecia areata ' a condition in which the immu...

Read more

15 Jul 2025 15:41

News

Sun Pharmaceutical Industries launches LEQSELVI' (deuruxolitinib) 8 mg tablets in United States

Sun Pharmaceutical Industries announced LEQSELVI' (deuruxolitinib) 8 mg tablets is now ava...

Read more

14 Jul 2025 16:48

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lupin Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Lupin Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Lupin Ltd is 85,203 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 390,863 Cr

What are the key factors driving the stock performance of Lupin Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Lupin Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lupin Ltd and Sun Pharmaceutical Industries Ltd?

As of August 2, 2025, the Lupin Ltd stock price is INR ₹1865.45. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1629.05.

How do dividend payouts of Lupin Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Lupin Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions